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Abstract 12 
Metabolic interactions, such as cross-feeding, play a prominent role in microbial community 13 
structure. For example, they may underlie the ubiquity of uncultivated microorganisms. We 14 
investigated this phenomenon in the human oral microbiome, by analyzing microbial metabolic 15 
networks derived from sequenced genomes. Specifically, we devised a probabilistic biosynthetic 16 
network robustness metric that describes the chance that an organism could produce a given 17 
metabolite, and used it to assemble a comprehensive atlas of biosynthetic capabilities for 88 18 
metabolites across 456 human oral microbiome strains. A cluster of organisms characterized by 19 
reduced biosynthetic capabilities stood out within this atlas. This cluster included several 20 
uncultivated taxa and three recently co-cultured Saccharibacteria (TM7) phylum species. 21 
Comparison across strains also allowed us to systematically identify specific putative metabolic 22 
interdependences between organisms. Our method, which provides a new way of converting 23 
annotated genomes into metabolic predictions, is easily extendible to other microbial 24 
communities and metabolic products.  25 
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Introduction 26 
Metabolism, in addition to enabling growth and homeostasis for individual microbes, is a 27 
powerful “currency”, that contributes to the organization of microbes into complex, dynamic 28 
societies. Metabolic interactions are believed to influence microbial community structure and 29 
dynamics at multiple spatial and temporal scales1–5. For example, through cross-feeding, a 30 
compound produced by one species might benefit another, leading to a network of metabolic 31 
interdependences5–10. An extreme case of interdependence between microbes is believed to 32 
underlie what is usually known as “microbial uncultivability”11, i.e. the fact that many microbes 33 
isolated from a given environment do not grow in pure culture on standard laboratory conditions. 34 
This observation, originally proposed as “the great plate count anomaly”12, has motivated interest 35 
in understanding the possible mechanisms underlying unculturability11,13,14. One class of 36 
mechanisms is based on the concept that the growth of uncultivable microbes depends on their 37 
community context via diffusible metabolites produced by their neighbors14. These dependent 38 
microbes are often referred to as fastidious, due to their limited biosynthetic capabilities and 39 
reliance on externally supplied metabolites for growth. The prominence of fastidious microbial 40 
organisms across the tree of life and their potential importance in microbial community structure 41 
is highlighted by the recent identification of the candidate phyla radiation – a large branch of the 42 
tree of life consisting mainly of uncultivated organisms with small genomes and unique 43 
metabolic properties15–17. 44 
Some of the most promising strides in understanding metabolic interdependences between 45 
microbes have been taken in the study of the human oral microbiome. The human oral 46 
microbiome serves as an excellent model system for microbial communities research, due to its 47 
importance for human health and ease of access for researchers18,19. For example, the order of 48 
colonization of species and the spatial arrangement of microbes in dental plaque have been 49 
thoroughly characterized20,21. The human oral microbiome consists of roughly 700 different 50 
cataloged microbial species, identified by 16S rRNA microbiome sequencing18,22. Importantly, 51 
63% of species in the human oral microbiome have been sequenced, including several 52 
uncultivated and recently-cultivated strains that have implications in oral health and disease23,24. 53 
Exciting recent work has led to successful laboratory co-culture growth of three previously 54 
uncultivated organisms, the Saccharibacteria (TM7) phylum taxa: Saccharibacteria bacterium 55 
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HMT-952 strain TM7x25,26, Saccharibacteria bacterium HMT-488 strain AC001 (not yet 56 
published), and Saccharibacteria bacterium HMT-955 strain PM004 (not yet published). 57 
Saccharibacteria are prominent in the oral cavity and relevant for periodontal disease27,28. Due to 58 
their importance, they were among the first uncultivated organisms from the oral microbiome to 59 
be fully sequenced via single-cell sequencing methods29, and represent the first cultivated 60 
members of the candidate phyla radiation25. Thus, their metabolic and phenotypic properties are 61 
of great interest for oral health and microbiology in general. 62 
In parallel to achieving laboratory growth of uncultivated bacteria, a major unresolved challenge 63 
is understanding the detailed metabolic mechanisms that underlie their dependencies. Ideally, 64 
one would want to computationally predict, directly from the genome of an organism, its 65 
biosynthetic capabilities and deficiencies, so as to translate sequence information into 66 
phenotypes, mechanisms, and community-level predictions30. A number of approaches, based on 67 
computational analyses of metabolic networks, have contributed significant progress towards this 68 
goal31–33, including in the context of microbial communities4,5,33–42. At the heart of these methods 69 
are metabolic network reconstructions, formal encodings of the stoichiometry of all metabolic 70 
reactions in an organism, that are readily amenable to multiple types of in silico analyses and 71 
simulations44. Recent exciting progress has led to the automated generation of “draft” metabolic 72 
network reconstructions for any organism with a sequenced genome45, opening the door for the 73 
quantitative study of large and diverse microbial communities. Despite this promise, the most 74 
commonly used metabolic network analysis methods, such as flux balance analysis (FBA)46 or 75 
its dynamic version (dFBA)47, are not applicable to these draft metabolic networks due to gaps 76 
(missing or incorrect reactions) in the metabolic network. Methods for “gap-filling” draft 77 
reconstructions can alleviate this problem at the expense of an increased risk for false positive 78 
predictions. Additionally, gap-filling requires specific assumptions on the growth media 79 
composition – which is often difficult to obtain for diverse environmental isolates and by 80 
definition unknown for uncultivated organisms. Thus, the capacity to provide predictions based 81 
on unelaborated genome annotation, and on limited knowledge about an organism’s growth 82 
environment remains an important open challenge. Metabolic network analysis methods that are 83 
less dependent on gap-filling have been applied to the analysis of draft metabolic 84 
reconstructions, generally with a focus on metabolic network topology48–50. Some of these 85 
methods have provided valuable insight into the biosynthetic potentials of organisms and 86 
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metabolites51,52, the chance of cooperation or competition between species53–56, and the 87 
relationship between organisms and environment48,57,58 including in the human gut 88 
microbiome59. However, these methods often depend on specific assumption on environmental 89 
conditions49,50, or cannot be easily reconciled with stoichiometry-based constraints48. 90 
Here we introduce a new method, which alleviates the above limitations, and provides a novel 91 
metabolic prediction – an estimate of biosynthetic network robustness. Our method applies a 92 
probabilistic approach to define and compute a metric that provides an estimate of which 93 
metabolites, such as biomass components, are robustly synthesized by a given metabolic network 94 
and which would likely need to be supplied from the environment/community. Discrepancies in 95 
these calculated estimates between organisms can be used to generate hypotheses regarding 96 
microbial auxotrophy and metabolic exchange in microbial communities. Importantly, our metric 97 
can provide an environment-independent characterization by randomly sampling many different 98 
possible nutrient combinations, and is not dependent on a priori biosynthetic pathway definitions 99 
as it depends only on the stoichiometric constraints of the metabolic network. We applied this 100 
method to a large number of organisms from the human oral microbiome, and identified broad 101 
trends in biosynthetic capabilities. We focused in particular on uncultivated microorganisms, 102 
including three recently co-cultured Saccharibacteria (TM7) strains. In addition to highlighting 103 
their biosynthetic deficiencies, we developed specific hypotheses for their metabolic exchange 104 
with growth-supporting co-culture partners.  105 
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Analysis Method  106 
Our newly developed method quantifies a concept we call biosynthetic network robustness. 107 
Robustness, in this sense, refers to the ability of the network to produce a specified target 108 
metabolite, from variable metabolic precursors. In essence, our metric for biosynthetic network 109 
robustness provides a measure of how well a particular metabolic network can produce a 110 
particular target across a uniformly sampled set of possible environments. 111 
The inspiration for this method comes from the statistical physics concept of percolation. 112 
Percolation theory has been applied broadly with applications ranging from materials science to 113 
epidemiology, as well as to the study of cascading metabolic failure upon gene deletions in 114 
metabolism60. In percolation theory the robustness of a network can be characterized by 115 
randomly adding or removing components (nodes or edges) of a network and assessing network 116 
connectivity61. We utilized this concept to characterize the network robustness of a particular 117 
metabolic network towards a specified target metabolite by randomly adding input metabolites to 118 
the network and assessing the network’s ability to produce the specified target metabolite. 119 
To implement our method, we first introduced a probabilistic framework for analyzing metabolic 120 
networks (Figure 1 A). In this framework, every metabolite can be considered to be drawn from 121 
a Bernoulli distribution, i.e. present in the network with a given input probability (Pin). These 122 
probabilities could represent beliefs about the environment, chances of metabolites being 123 
available from a host organism, or any arbitrary prior on metabolite inputs. Throughout the 124 
implementation of our method, we have assigned Pin to be an identical value for all input 125 
metabolites. However, future implementations of this probabilistic framework could easily 126 
utilize Pin values that vary across metabolites, e.g. matching experimentally measured 127 
abundances. Following the assignment of Pin, the network structure can be used to calculate the 128 
output probability (Pout) of some specified target metabolite. In practice, random sampling of 129 
probabilistically drawn input metabolite sets is used to calculate the probability of producing the 130 
target metabolite. For each random sample, flux balance analysis46 with inequality mass balance 131 
constraints is used to assess the networks ability to produce the target metabolite (for a complete 132 
explanation of how flux balance analysis is implemented in this context, see methods section: 133 
Algorithm functions, feas). 134 
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 135 
Figure 1: Biosynthetic network robustness analysis framework 136 
A probabilistic framework was developed to calculate the biosynthetic network robustness of a given metabolic 137 
network and target metabolite. 138 
(A) Input probabilities (Pin) are assigned to each input metabolite to designate the probability of adding that 139 
metabolite to the network. For our implementation, each input metabolite is assigned an identical Pin value. Random 140 
sets of input metabolites are sampled, based on Pin, and a modified version of flux balance analysis is used to 141 
determine if the network can produce a specified target output metabolite for each random sample. Many random 142 
samples are taken to estimate the output probability (Pout) of the target output metabolite. Three examples of Pin 143 
values and the corresponding Pout values are shown for a very simple network and target output metabolite. The 144 
output probabilities here were calculated using the probabilistic equation 𝑃𝑜𝑢𝑡 = 1 − [(1 − 𝑃𝑖𝑛)
2 ∗ (1 − 𝑃𝑖𝑛
2)] =145 
2𝑃𝑖𝑛 − 2𝑃𝑖𝑛
3 + 𝑃𝑖𝑛
4. For more information on this equation please refer to Supplementary Figure 1. 146 
(B) A producibility curve can be calculated which represents Pout as a function of Pin. Points along this curve can be 147 
sampled by assigning the Pin value and estimating Pout. The three examples from A are shown in red on the curve in 148 
B. The producibility metric (PM) is used to summarize the producibility curve, and quantifies biosynthetic network 149 
robustness. It is defined by the value of Pin at which Pout equals 0.5, analogous to the Km value of the Michaelis-150 
Menten curve. PM is equal to 1 minus this value, such that increasing PM correspond to increasing biosynthetic 151 
network robustness.  152 
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The probabilistic method that we introduced allows the definition of two novel concepts, the 153 
“producibility curve” and “producibility metric” (PM) (Figure 1 B). The producibility curve is a 154 
plot of Pout as a function of Pin. For a given metabolic network and metabolite target, this curve 155 
can be estimated by sampling input metabolites for different values of Pin (between 0 and 1), and 156 
calculating Pout (Figure 1 B red points). The PM is a single metric which encapsulates 157 
biosynthetic network robustness by summarizing the producibility curve. The PM is defined by 158 
the Pin value along the producibility curve at which Pout is equal to 0.5. The PM value is equal to 159 
1 minus this Pin value, by convention, such that larger PM values correspond to increased 160 
robustness. An analogy can be drawn between the mathematical representation of PM and the 161 
half maximal concentration constant Km in the Michaelis-Menten sigmoidal curve. Our method 162 
calculates PM efficiently by random sampling and a nonlinear fitting algorithm (for details, see 163 
methods section: Algorithm functions calc_PM_fit_nonlin). In addition to being quantified 164 
computationally for arbitrary metabolic networks and metabolites, the PM can also be obtained 165 
analytically by using combinatorial considerations (see Supplementary Figure 1). This analytical 166 
result clarifies the connection between our metric and the concept of minimal precursor sets62, 167 
and could serve as the basis for further theoretical work on the fundamental properties of 168 
metabolic networks. 169 
The algorithms used to implement our method are written in MATLAB and designed as a set of 170 
modular functions that interface with the COBRA toolbox – a popular metabolic modeling 171 
software compendium63,64. The methodology behind each function is further explained in the 172 
methods section. The code is freely available online at 173 
https://github.com/segrelab/biosynthetic_network_robustness.  174 
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Results 175 
Analysis of the E. coli core metabolic network 176 
Before applying our approach to the systematic study of genome-scale metabolic networks from 177 
the human oral microbiome, we used a simpler, well characterized metabolic network model to 178 
illustrate its performance and interpretation. We applied our method to the E. coli core metabolic 179 
network, a simplified representation of E. coli metabolism consisting of central carbon 180 
metabolism and lacking peripheral metabolic pathways, such as amino acid or cofactor 181 
biosynthesis65. We analyzed the biosynthetic network robustness of the E. coli core metabolic 182 
network by calculating the PM value for all intracellular metabolites in this network. The results 183 
are shown in Figure 2 A, overlaid on the metabolic network, with each node’s color indicating its 184 
PM value and node size indicating its degree. The E. coli core metabolic network is highly 185 
connected and this leads to most metabolites having high PM values (PM > 0.950), matching 186 
expectations. For example, the metabolites H+ and pyruvate are both highly connected in the 187 
metabolic network and have high biosynthetic network robustness (PM = 0.968 and 0.952 188 
respectively). However, the network also contains several metabolites that are well connected, 189 
but have low PM values. These include, for example, the cofactors AMP/ADP/ATP and 190 
NAD+/NADH, which have PM values of ~0.7 and ~0.5 respectively, because they can be 191 
recycled from each other, but not biosynthesized in this network. The network also includes 192 
several examples of the opposite situation, i.e. metabolites that are poorly connected but have 193 
high PM values. One example is D-lactate, which is produced via Lactate Dehydrogenase (LDH) 194 
from the high PM metabolites Pyruvate and H+ (Figure 2 B). This reaction also consumes NADH 195 
and produces NAD+, but because these cofactors can be easily recycled from each other by a 196 
large number of different reactions they have minimal influence on the PM value of D-lactate 197 
(Figure 2 B). This example demonstrates the fact that our metric captures metabolites which are 198 
easily produced because their precursors are easily produced, and that the utilization of recycled 199 
cofactors has minimal influence on the PM. Overall, there is no significant correlation between 200 
the PM values and the node degree of a metabolite in the network (Supplementary Figure 2), 201 
indicating that our metric describes a unique property of a metabolite in a metabolic network that 202 
is not captured simply by node degree.  203 
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 204 
Figure 2: Biosynthetic network robustness of the E. coli core metabolic network 205 
We calculated the producibility metric (PM) for all intracellular metabolites in the E. coli core metabolic network to 206 
demonstrate the implementation of our method on a simple network. 207 
(A) The network is represented as a bipartite graph with metabolites shown as circles and reactions shown as 208 
squares. Reactions shown with a green border are reversible in the model. All intracellular metabolites are colored 209 
based on their PM value (low – blue, high – red). Reactions and metabolite nodes are sized based on their total node 210 
degree. Several key metabolites of interest are highlighted with their corresponding PM values shown. Central 211 
metabolites such as H+ and Pyruvate have high degree and high PM. Cofactors such as AMP/ADP/ATP and 212 
NAD+/NADH have high degree but low PM, as they cannot be biosynthesized in this network. Oxygen is an 213 
example of a PM 0 metabolite that cannot be produced from any other metabolites in this network. D-lactate is an 214 
example of a metabolite with low degree and high PM i.e. it is easily produced but not well-connected. 215 
(B) Reactions related to the cofactors NAD+ and NADH are shown in a separate panel. The top reaction, Lactate 216 
Dehydrogenase (LDH), is shown with all substrates while all other reactions are shown without additional 217 
substrates. The metabolite D-lactate has high PM despite being poorly connected in the metabolic network because 218 
it can be produced from the high PM metabolites pyruvate and H+ via LDH. This reaction also consumes NADH and 219 
produces NAD+, however these cofactors have minimal impact on the PM because they are easily recycled in the 220 
network by a large number of different reactions.  221 
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Reconstruction of human oral microbiome metabolic networks 222 
We next applied our method to the human oral microbiome, aiming at a mechanistic 223 
characterization of the biochemical capabilities of different microbes based on metabolic 224 
networks reconstructed directly from their genomes. As a first step, we reconstructed metabolic 225 
networks for 456 different microbial strains representing a diverse set of human oral microbes, 226 
whose annotated genomes were available from the Human Oral Microbiome Database (see 227 
methods section for details). These organisms represent 371 different species, 124 genera, 64 228 
families, 35 orders, 22 classes, and 12 phyla. Metadata related to the selected organisms can be 229 
found in Supplementary Table 1. Notably, the database includes several sequenced yet 230 
uncultivated or recently co-cultured organisms. This fact, together with the unique flexibility of 231 
our analysis, allowed us to obtain insight into these microbes. In particular, the following 232 
sequenced yet uncultivated, or recently co-cultured, strains were included in our analysis: 233 
Saccharibacteria (TM7) bacterium HMT-952 strain TM7x25, Saccharibacteria (TM7) bacterium 234 
HMT-955 strain PM004, Saccharibacteria (TM7) bacterium HMT-488 strain AC001, 235 
Tannerella HMT-286 strain W1166766, Anaerolineae (Chloroflexi phylum) bacterium HMT-439 236 
strain Chl267, Absconditabacteria (SR1) bacterium HMT-874 strain MGEHA68, and 237 
Desulfobulbus HMT-041 strains Dsb2 and Dsb369. All of the selected genomes were used to 238 
reconstruct sequence-specific draft metabolic networks using the Department of Energy Systems 239 
Biology Knowledgebase (KBase) and the build metabolic model app45,70,71. The networks were 240 
reconstructed without any gap-filling to increase the specificity of the resulting predictions. A 241 
KBase narrative containing the genomes and draft metabolic network reconstructions can be 242 
found at: https://narrative.kbase.us/narrative/ws.27853.obj.935. The complete collection of all 243 
network models is also available for download in MATLAB (.mat) format at 244 
https://github.com/segrelab/biosynthetic_network_robustness. 245 
Large-scale analysis of biosynthetic capabilities across the human oral microbiome 246 
We analyzed the biosynthetic network robustness for 88 different biomass metabolites across the 247 
aforementioned 456 metabolic networks from the human oral microbiome. The 88 biomass 248 
metabolites included all biomass building blocks considered to be essential for either Gram-249 
negative or Gram-positive biomass, as listed in the KBase build metabolic models app45,70,71 250 
(listed in Supplementary Table 2). Through this analysis we calculated 40,128 PM values which 251 
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represent an atlas of biosynthetic capabilities across these human oral microbiome organisms. 252 
The ensuing atlas is represented as hierarchically bi-clustered PM values for all 456 organisms 253 
and 88 metabolites in Figure 3. The same data is available in Supplementary Figure 3 (clustered 254 
by taxonomy), and in Supplementary Table 3. 255 
The hierarchically clustered heat map (Figure 3) shows extensive variability in the PM values of 256 
different organisms and metabolites across the oral microbiome. There are three main large 257 
clusters of metabolites: one cluster with consistently high PM (top), one cluster with low PM 258 
values (middle), and one cluster with variable PM (bottom). Different classes of metabolites 259 
cluster quite differently across this landscape. In addition to simple ubiquitous metabolites, such 260 
as H2O or glycine (Figure 3 I), all nucleotides have high PM across the oral microbiome 261 
organisms. Amino acids generally have high PM as well, with the notable exception of L-262 
tryptophan (Figure 3 II). Interestingly, L-tryptophan is known to be a particularly difficult amino 263 
acid to synthesize72. Metal ions generally had PM value of 0 across all organisms, serving as an 264 
expected negative control. Some exceptions, such as Mg2+, Co2+, Cl-, Fe3+, and Fe2+, can be 265 
explained based on their presence in larger compounds, such as porphyrins. For example, Co2+ 266 
has increased PM values in a pattern that closely follows the PM values of the cobalt containing 267 
vitamin cobamamide (Figure 3 III).  268 
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 269 
Figure 3: Human oral microbiome organisms biosynthetic network robustness matrix 270 
The producibility metric (PM) was calculated for 456 different oral microbiome organisms (columns) and 88 271 
different essential biomass metabolites (rows). The resulting matrix is hierarchically bi-clustered based on average 272 
distances between organisms and metabolites PM values. Organism Gram-stain and phylum/class are indicated by 273 
several annotation columns at the top of the matrix. The biomass metabolites analyzed consisted of several different 274 
types of metabolites indicated with different colors. Several metabolites that showed interesting patterns across oral 275 
microbiome organisms are highlighted with roman numerals. The most distinct cluster of organisms is highlighted 276 
and annotated (top left), which consisted of fastidious reduced-genome organisms (Mycoplasma, Treponema) and 277 
uncultivated or recently cultivated organisms (SR1, TM7, Desulfobulbus, Anaerolineae).  278 
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Before analyzing in detail the patterns identifiable in the PM atlas of Figure 3, we showed that 279 
such patterns cannot be trivially attributed to simple broad properties, such as genome size, even 280 
if genome size is known to be an important predictor of the overall biosynthetic capabilities of an 281 
organism73. Fastidious or parasitic organisms tend to have reduced genomes and consequently 282 
reduced metabolic capabilities. In our data, the overall average PM value for each organism can 283 
be partially predicted by genome size. A linear regression model and quadratic regression model 284 
which used the log of genome size to predict the average PM value across all metabolites for 285 
each organism had R2 values of 0.498 and 0.551 respectively (Supplementary Figure 4A). 286 
However, by using Akaike information criterion (AIC) and Bayesian information criterion (BIC) 287 
statistical analyses74 (Supplementary Figure. 4B, C), we found that adding taxonomic parameters 288 
to these regression models significantly improved model performance. This indicates that our 289 
data contains additional structure beyond simply genome size. In particular, both the AIC and 290 
BIC improve up to at least the order level indicating that there is additional structure up to this 291 
taxonomic level. 292 
We further investigated, quantitatively, the associations between different taxonomic groups and 293 
the PM values of various metabolites by calculating the log likelihood ratio between a quadratic 294 
regression model predicting the PM values for a particular metabolite based solely on genome 295 
size against one that incorporates a specific taxonomic parameter of interest (Supplementary 296 
Figure 5, methods). This allowed us to highlight metabolites with highly significant increased or 297 
decreased PM values in certain taxonomic groups, and to confirm patterns that we observed by 298 
eye in Figure 3 and Supplementary Figure 3. These patterns and observations are elaborated in 299 
the following section. 300 
Capturing specific biosynthetic patterns across human oral microbiome organisms 301 
Numerous patterns and details of the atlas of biosynthetic capabilities captured by the PM values 302 
(Figure 3) could be relevant for addressing specific biological questions or model refinement 303 
challenges. Here we focus in detail on two specific classes of compounds: (i) cell-wall and 304 
membrane components, which tend to vary broadly across organisms, and are important for 305 
antimicrobial susceptibility and immune system recognition; and (ii) amino acids and essential 306 
factors (e.g. vitamins), which could be relevant for understanding metabolic exchange among 307 
bacteria and with the host. 308 
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A first striking pattern in the atlas of biosynthetic capabilities captured by the PM values (Figure 309 
3) is the complexity of cell-wall and membrane components of different taxa. Some aspects of 310 
this pattern are consistent with standard attribution of metabolites associated with the Gram 311 
staining categories (estimated using the KBase build metabolic model app45,70,71). However, we 312 
also observed interesting deviations, which could be partially attributed to known finer resolution 313 
in the specific membrane components across taxa. Compared to other metabolites, cell-wall 314 
components generally tend to have variable or low PM values across the oral microbiome 315 
organisms. We analyzed in detail fifteen different teichoic acids, a class of metabolites expected 316 
to be found in the cell wall of Gram-positive organisms that play an important role in microbial 317 
physiology and interactions with the host75. Of these, nine were found to have higher PM values 318 
in Gram-positive organisms, as expected (Figure 3 IV). In particular, the D-alanine substituted 319 
lipoteichoic acids had high PM values in the phylum Firmicutes and specifically the class 320 
Bacilli. However, there was another set of 6 teichoic acids that had intermediate PM values 321 
across a large number of organisms and didn’t follow Gram-staining trends (Figure 3 V). These 322 
consisted of three N-acetyl-D-glucosamine linked and three unsubstituted teichoic acids. As 323 
detailed in Supplementary Text 1, the increased PM for this teichoic acid in many Gram-negative 324 
species can be attributed to the presence of a specific gene76–78 that may merit closer inspection 325 
in the network reconstruction process. 326 
We further observed clear trends associated with several lipids which are expected to be found in 327 
the cell membrane of both Gram-positive and Gram-negative organisms. In particular, we found 328 
a strong increase in the PM value for three phosphatidylethanolamine lipids in Gram-negative 329 
organisms (Figure 3 VI). Interestingly, these lipids have been previously observed to be more 330 
commonly produced in Gram-negative organisms, and have implications for antimicrobial 331 
susceptibility79,80. We also identified trends associated with three cardiolipin and three 332 
phosphatidylglycerol lipids that display generally similar PM patterns across different species 333 
(Figure 3 VII). One class of organisms that stands out with respect to lipid biosynthesis are the 334 
Negativicutes. These organisms have relatively high PM values for phosphatidylethanolamine 335 
but PM values of 0 for cardiolipin and phosphatidylglycerol lipids. Consistent with this result, it 336 
has been previously observed that the Negativicutes organism Selenomonas ruminantium lacks 337 
cardiolipin and phosphatidylglycerol lipids in its inner and outer cell membranes, but does have 338 
phosphatidylethanolamine81. It has been hypothesized that the membrane stabilizing role of these 339 
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two missing lipids could be partially fulfilled by peptidoglycan bound polyamines, including 340 
spermidine, in Selenomonadales organisms81,82. Concordantly, we see an increased PM value for 341 
the polyamine spermidine across Negativicutes in our data (Figure 3 VIII). 342 
Aside from lipids and cell-wall components, there are a number of interesting trends related to 343 
several amino acids and other essential factors in our data. A number of metabolites had notably 344 
increased PM in the phylum Proteobacteria and decreased PM values in the phylum 345 
Bacteroidetes. A notable example is heme, which can be seen to follow this trend (Figure 3 IX). 346 
Heme plays an important role in microbe host interactions, as bacterial pathogens often acquire it 347 
from their human host83. In the context of the human oral microbiome, the oral pathogen 348 
Porphyropmonas gingivalis (belonging to the class Bacteroidetes) is known to scavenge heme84, 349 
compatible with the above pattern. Other metabolites that displayed the same trend include: L-350 
arginine, L-cysteine, L-methionine, L-tryptophan, and glutathione. L-arginine can be catabolized 351 
via the arginine deiminase pathway to regenerate ATP and is thus an interesting exchange 352 
metabolite beyond its use as a protein building block85,86. L-tryptophan is one of the highest cost 353 
amino acids to biosynthesize72, and thus is an intriguing exchange candidate. L-methionine and 354 
L-cysteine are the only two sulfur containing standard amino acids, and glutathione is 355 
synthesized from L-cysteine. It’s possible that the discrepancies between PM values observed 356 
here are indicative of broad amino acid and vitamin exchange between the classes 357 
Proteobacteria and Bacteroidetes in the human oral microbiome. 358 
Uncovering biosynthetic deficiencies in fastidious human oral microbiome organisms 359 
In addition to dissecting the patterns associated with specific metabolites, one can analyze the 360 
PM landscape of Figure 3 from the perspective of the organisms and their agglomeration into 361 
clusters. Given their importance in disease and the unresolved challenges related to their reduced 362 
metabolic capabilities, we focused specifically on fastidious human oral microbiome organisms. 363 
Strikingly, in our large clustered PM matrix, the most distinct hierarchical cluster of organisms 364 
consisted of a number of fastidious organisms (Figure 3 top left). This cluster included all of the 365 
Mycoplasma genomes that we analyzed, and one Treponema genome. Mycoplasma and 366 
Treponema are genera that are known to be parasitic and have evolved to have reduced genomes 367 
and metabolic capabilities87–91. The remaining members of this cluster included nearly all of the 368 
sequenced yet uncultivated, or recently co-cultured, organisms in our study. The organisms 369 
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included were from the phyla: Absconditabacteria (SR1), Saccharibacteria (TM7), 370 
Proteobacteria (genus Desulfobulbus), and Chloroflexi (class Anaerolineae). Only one of the 371 
previously uncultivated organism we analyzed was found outside of this fastidious cluster, 372 
namely Tannerella HMT-286. Interestingly, this bacterium is hypothesized to rely on externally 373 
supplied siderophores to support its growth66. This type of protein dependency is not captured by 374 
our metabolic analysis and highlights the fact that, while uncultivability can be driven by many 375 
different mechanisms, our method captures the prominent effect of reduced metabolic capacity. 376 
The other uncultivated organisms that we identified in this cluster have been hypothesized to 377 
have reduced genomes and limited metabolic capabilities underlying their fastidious nature, 378 
much like Mycoplasma. 379 
We sought to gain clearer insight into the metabolic properties of these co-clustered fastidious 380 
organisms by re-clustering their PM submatrix (Figure 4 A). By comparing the PM values in this 381 
fastidious cluster to those in the average oral microbiome organisms, it is clear that the fastidious 382 
organisms had reduced PM values for a large number of metabolites including cell-wall 383 
components, lipids, amino acids, and other essential factors. When ranking metabolites by their 384 
difference in average PM between all oral microbiome organisms and the fastidious cluster a 385 
number of amino acids and vitamins stand out as being the most depleted in the fastidious 386 
cluster. The top metabolites where: pyridoxal phosphate, L-valine, putrescine, L-isoleucine, 387 
bactoprenyl diphosphate, thiamin diphosphate, 5-methyltetrahydrofolate, L-lysine, 388 
deoxyguanosine triphosphate, L-tryptophan, and guanosine-triphosphate. These metabolites may 389 
be particularly relevant with regards to exchange between fastidious organisms and their oral 390 
microbiome community partners. Amino acids, in particular, have been hypothesized to be 391 
involved in metabolic exchange between microbial organisms in communities1, 7, 37,92. Notably, 392 
amino acids with reduced PM in the fastidious cluster (i.e. amino acids more readily produced by 393 
other organisms) tend to be among the more costly ones72, as indicated by a Spearman 394 
correlation analysis (ρ = 0.4595, P-value = 0.0415). An exception to this trend, potentially 395 
interesting for follow up studies, is the case of the branched chain amino acids L-valine, and L-396 
isoleucine, which are the two amino acids with most reduced PM in fastidious organisms, but are 397 
not among the costliest. Notably, branched chain amino acid supplementation has been shown to 398 
alter the metabolic structure of the gut microbiome of mice93.  399 
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400 
Figure 4: Biosynthetic network robustness sub-matrices for fastidious/uncultivated and TM7/host organisms 401 
Sub-matrices of the larger biosynthetic network robustness matrix were re-clustered to highlight variations within 402 
specific groups of fastidious and uncultivated organisms. 403 
(A) The fastidious/uncultivated organisms that were identified as the most unique cluster in the larger matrix from 404 
Figure 3 were re-clustered hierarchically based on average distance between organisms and metabolites 405 
producibility metric (PM). The average PM value across all oral microbiome organisms analyzed in this study is 406 
shown in the far left column. Differences between the fastidious Mycoplasma genus and the previously uncultivated 407 
TM7 species are highlighted. 408 
(B) The PM values for the previously uncultivated TM7 species and their co-culture growth-supporting hosts 409 
bacteria were extracted and re-clustered hierarchically based on average distance between organisms and 410 
metabolites PM values. Differences between the TM7 species and their bacterial hosts are highlighted.  411 
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To gain more specific insight into a specific class of recently-cultivated fastidious organisms, 412 
Saccharibacteria (TM7), we further focused our analysis on identifying discrepancies between 413 
Mycoplasma and TM7. Our analysis included eight Mycoplasma genomes and three TM7 414 
genomes. Mycoplasma are a relatively well characterized genus of intracellular parasites with 415 
reduced metabolic capabilities, and TM7 are a recently co-cultured phylum of the candidate 416 
phyla radiation that display reduced metabolic capabilities and a parasitic lifestyle. Comparing 417 
these two groups of organisms gives deeper insight into the unique metabolic capabilities of 418 
each. There are several cell-wall components for which TM7 has relatively high PM values and 419 
Mycoplasma has PM values of zero (Figure 4 I). These include nine different teichoic acids, 420 
bactoprenyl diphosphate, and peptidoglycan. This highlights extensive cell-wall/peptidoglycan 421 
metabolism in TM7 organisms and the known lack of a cell-wall in Mycoplasma91. Furthermore, 422 
a set of three nucleotides: dGTP, GTP, and TTP, have high PM values for TM7 and PM values 423 
of zero for Mycoplasma organisms (Figure 4 II). This pattern of nucleotide biosynthesis 424 
deficiency in Mycoplasma is consistent with the observation that some strains have been shown 425 
to be dependent on supplementation of thymidine and guanosine but not adenine or cytosine 426 
nucleobases for growth94. Finally, the cofactors acyl carrier protein (ACP) and flavin adenine 427 
dinucleotide (FAD) had high PM values in Mycoplasma and PM values of zero in TM7 428 
organisms (Figure 4 III). The lack of these cofactors in TM7 seems surprising, but is indeed 429 
matched by a complete lack of any metabolic reactions annotated to utilize FAD and ACP as 430 
cofactors in the draft reconstruction of the TM7 metabolic networks. 431 
In addition to investigating the metabolic deficiencies of fastidious organisms, the PM landscape 432 
gave us the opportunity to compare these gaps with possible complementary capabilities in 433 
organisms known to support their growth. The three TM7 strains that we analyzed were recently 434 
co-cultured with host bacteria from the human oral microbiome. TM7x was shown to be a 435 
parasitic epibiont of Actinomyces odontolyticus XH00125,26,95. TM7 AC001 and PM004 were 436 
recently both co-cultured successfully with either of the host strains Pseudopropionibacterium 437 
propionicum F0230a or F0700 (not yet published). We sought to further investigate these newly 438 
discovered relationships to gain insight into possible metabolic exchange (Figure 4 B). 439 
Interestingly, TM7 organisms had higher PM values than their host strains for several cell-wall 440 
components: three glucose-substituted teichoic acids, and glucose-substituted and unsubstituted 441 
glycerol teichoic acid (Figure 4 IV), suggesting that TM7 is capable of producing several cell-442 
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wall components that its host cannot. Conversely, as expected, a large number of metabolites had 443 
increased PM values in the host strains compared to the TM7 strains. These metabolites are 444 
hypothesized to be easily synthesized by the host and not TM7 and are thus interesting 445 
candidates for growth supporting exchange in co-culture. Fourteen different metabolites had 446 
average PM values in the hosts greater than 0.60 higher than in the TM7 organisms (Figure 4 V). 447 
The ranked list includes: L-isoleucine, L-valine, acyl carrier protein, 5-methyltetrahydrofolate, 448 
pyridoxal phosphate, flavin adenine dinucleotide, thiamin diphopsphate, putrescine, L-449 
tryptophan, Fe2+, heme, Fe3+, L-lysine, and menaquinone-8. Interestingly, the branched chain 450 
amino acids L-isoleucine and L-valine are again at the top of the list. The correlation of amino 451 
acid biosynthesis cost72 with the difference in PM values between host and TM7 is even higher 452 
than what we observed across all fastidious organisms (Spearman correlation ρ = 0.6011, P-value 453 
= 0.0051). 454 
Our results provide context and putative mechanistic details related to observed gene expression 455 
and metabolic changes in TM7-host co-culture. In particular, the first and currently only 456 
published work on co-culture involving TM7 is the one on TM7x with the host Actinomyces 457 
odontolyticus XH00125,26,95. Transcriptomic data for the co-culture of TM7x and A. odontolyticus 458 
XH001 showed that a number of genes associated with N-acetyl-D-glucosamine were up 459 
regulated in A. odontolyticus in this interaction. Our results show that, although TM7 does have 460 
extensive cell wall metabolism, A. odontolyticus has higher PM for N-acetyl-D-glucosamine 461 
substituted components (Figure 4 VI). This suggests that the host is responsible for the 462 
biosynthesis of these cell-wall components, which may be overexpressed in co-culture. 463 
Metabolomics experiments from this co-culture have identified the cyclic peptide cyclo(L-Pro-L-464 
Val) as a potential signaling molecule in this relationship. Our PM analysis suggests that this 465 
molecule would be synthesized by the host as it has increased PM values for both of the amino 466 
acids included (Figure 4 VII). In fact, L-valine has one of the highest discrepancies in PM for 467 
host and TM7. Finally, another potentially exchanged amino acid of interest is L-arginine. All 468 
three TM7 draft metabolic network reconstructions that we analyzed were annotated to possess 469 
either all or all but one of the reactions in the arginine deiminase pathway (TM7 PM004 is 470 
missing the arginine iminohydrolase reaction) (See also supplementary figure 6 and interactive 471 
Cytoscape96 file for a representation of the full metabolic network for each TM7 strain including 472 
PM calculations for all intracellular metabolites and subnetworks of the arginine deiminase 473 
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pathway, Supplementary Files 1-3). This catabolic pathway can be used to degrade L-arginine to 474 
regenerate ATP, and has been implicated in syntrophic microbial interactions85,86. In our PM 475 
analysis L-arginine had consistently higher PM in host than TM7 (Figure 4 VIII). Thus, L-476 
arginine exchange and metabolism via the arginine deiminase pathway could contribute to the 477 
dependence of TM7 on its hosts (Figure 5).  478 
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 479 
Figure 5: Hypothesized metabolic exchange between TM7 and their bacterial hosts 480 
(A) Hypotheses were generated regarding the exchange of metabolites between TM7 species and their bacterial 481 
hosts by comparing their producibility metric (PM) across essential biomass metabolites. Many metabolites of 482 
different types were observed to have higher PM values in one set of organisms when compared to the other (arrows 483 
point from high to low). 484 
(B) The cell-wall components containing glucose-substituted teichoic acids were among the only metabolites with 485 
PM higher in TM7 than in hosts. N-acetyl-D-glucosamine-substituted teichoic acids had increased PM in the host 486 
relative to TM7, and previous gene expression data from the co-culture of TM7x and A. odontolyticus shows several 487 
genes related to N-acetyl-D-glucosamine that are overexpressed in A. odontolyticus during co-culture25. 488 
(C) Several vitamins/cofactors/other essential factors had significantly decreased PM in TM7 compared to the hosts. 489 
The cofactors acyl carrier protein and flavin adenine dinucleotide had decreased PM in TM7, and were also not 490 
found to be utilized in the TM7 draft metabolic network reconstructions. 491 
(D) Several amino acids had significantly decreased PM in TM7 compared to the hosts. L-valine and L-proline were 492 
both decreased in TM7 relative to the host, and previous metabolomics data from the co-culture of TM7x and A. 493 
odontolyticus identified the cyclic dipeptide cyclo(L-Pro-L-Val) as a potential signaling molecule25. L-arginine had 494 
decreased PM in TM7 relative to the host and could potentially be exchanged and catabolized by TM7 via the 495 
arginine deiminase pathway.  496 
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Discussion 497 
We have developed a novel method for analyzing the biosynthetic capabilities of microbial 498 
organisms based on draft metabolic networks reconstructed directly from genomic information. 499 
Our method provides a preliminary assessment of the biosynthetic capabilities of a metabolic 500 
network model, without the need for gap-filling, that can be used to gain biological insight and 501 
evaluate initial model performance. The concept we define, biosynthetic network robustness, 502 
provides an environment-independent evaluation and utilizes all available stoichiometric 503 
constraints. Environmental independence is achieved by randomly sampling many possible 504 
nutrient combinations in a probabilistic manner and computing a metric inspired by percolation 505 
theory. This measure defines the robustness with which an organism can produce a given 506 
metabolite from any random set of precursors and thus avoids the issue of metabolite 507 
producibility being inherently dependent on environment49,50. In this work we have chosen to 508 
calculate the metabolic properties of organisms without assuming a particular environment; 509 
however, future implementations could utilize environmental information in a probabilistic 510 
manner when appropriate. Additionally, we have analyzed the production of individual target 511 
metabolites, but our method could easily be extended to sets of metabolites such as the 512 
simultaneous production of all biomass components. Our method utilizes all available 513 
stoichiometric constraints of the metabolic network as opposed to an adjacency matrix used by 514 
alternative approaches48. Stoichiometric constraints are implemented with a modified version of 515 
flux balance analysis (See methods section algorithm functions: feas), as opposed to the 516 
alternative network expansion algorithm to avoid the dependence on cofactors as bootstrapping 517 
metabolites97. 518 
It is important to highlight that several assumptions are made in the representation of enzymatic 519 
reactions as a network that generally limit metabolic network analysis methods. The primary 520 
limitation is in enzyme annotation. Aside from missing or incorrect annotations, subtle processes 521 
such as enzyme promiscuity and spontaneous reactions may have unquantified effects on 522 
metabolic network function. Reaction direction/reversibility is also difficult to predict as it 523 
requires detailed knowledge of reaction thermodynamics and metabolite concentrations. In 524 
particular, inaccurate or missing information about reaction direction/reversibility could lead to 525 
uncertainty about whether a high PM from our method should be interpreted as reflecting 526 
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biosynthetic or degradative capabilities (or both). Throughout our analysis we have utilized 527 
default reversibility constraints provided by the KBase build metabolic models app45,70,71, but 528 
more stringent constraints on directionality could possibly improve our results. Additionally, as 529 
our method analyzes local properties of the metabolic network (the PM value for a specific 530 
metabolite) unidentified gaps in biosynthetic pathways that occur in close proximity to the target 531 
metabolite of interest could lead to incorrect predictions regarding microbial auxotrophy. In 532 
general, all metabolic network analysis methods face similar limitations. Even as newly 533 
developed experimental methods gradually improve metabolic reaction annotation98–101, it is 534 
likely that we will have to continue dealing with incomplete knowledge. Thus, approaches such 535 
as ours are valuable for initial assessment of metabolic capabilities with minimal arbitrary 536 
assumptions, and unexpected modeling results can help to pinpoint specific areas in need of 537 
refinement. 538 
In applying our method to the human oral microbiome, we computed an atlas of biosynthetic 539 
capabilities across organisms that can be mined for relevant biological insight. Overall, many of 540 
our predictions were consistent with known patterns such as the reduction in biosynthetic 541 
capabilities in the genus Mycoplasma or the distribution of lipids and cell-wall components in 542 
Gram-positive and negative organisms. Additionally, unexpected predictions served as 543 
opportunities to highlight novel biological patterns or emphasize areas of the metabolic network 544 
that merit additional attention in the network reconstruction process. Our focus was on fastidious 545 
and uncultivated organisms in particular, and using our method we highlighted a unique cluster 546 
of such organisms with reduced biosynthetic capabilities. This cluster included three previously 547 
uncultivated Saccharibacteria (TM7) phylum organisms that were recently successfully co-548 
cultured with growth supporting bacterial host organisms. Our method singled out specific 549 
biosynthetic capabilities of these organisms, and was used to develop hypotheses regarding 550 
metabolic exchange between TM7 and host bacteria that give context to existing co-culture data 551 
and should be further testable in future experiments. These three TM7 species are the first 552 
successfully cultured organisms from the candidate phyla radiation and therefore are of general 553 
interest beyond their role in human oral health. In fact, the recent identification of the candidate 554 
phyla radiation demonstrates the broad prevalence across the tree of life of reduced-genome 555 
organisms that potentially rely on their community context for metabolic supplementation15–17. 556 
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Further analysis of these organisms with our method could continue to provide insight into their 557 
unique metabolic properties.  558 
By quickly translating genotype into phenotype with minimal assumptions, our approach has the 559 
potential to serve as a baseline estimate of metabolic mechanisms in different microbial 560 
communities and allows us to more easily decipher microbial community structure and function. 561 
Our method can be easily applied other human-associated or environmentally relevant microbial 562 
communities, providing valuable putative insight into inter-microbial metabolic dependencies, 563 
that could be used to interpret existing data or design future experiments. In particular, we 564 
envisage that this type of metabolic insight could help bridge the gap between correlation studies 565 
and a mechanistic understanding of microbial community metabolism and dynamics.  566 
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Methods 567 
Method implementation 568 
The framework for implementing our method was developed as several different modular 569 
functions that interact in a nested manner to run our analysis. The structure of these functions 570 
and their associated variables is described in Supplementary Figure 7 via a code diagram. The 571 
functions are written in MATLAB and interface with the COBRA toolbox63,64. The code is built 572 
around the COBRA toolbox commands changeObjective and optimizeCbModel. Thus, running 573 
our code requires installation of the COBRA toolbox. Additionally, the nonlinear fitting function 574 
utilizes the MATLAB function lsqnonlin for nonlinear least squared fitting. Additional functions 575 
were developed to implement our probabilistic framework and run our analysis method. Any of 576 
these functions could be replaced with alternative modules that improve or expand upon the 577 
algorithm in the future. We describe here each modular function, providing details on the 578 
computations performed. The full code for implementing our method is available online at 579 
https://github.com/segrelab/biosynthetic_network_robustness. 580 
Algorithm functions 581 
feas – This function determines if the production of a given target metabolite set is feasible given 582 
the metabolic network model with specified constraints. Flux balance analysis was used to 583 
determine the feasibility of production46. Flux balance analysis was chosen over the alternative 584 
network expansion algorithm due to its treatment of cofactor metabolites97. In network 585 
expansion, cofactors must be added to the network to “bootstrap” metabolism, whereas in flux 586 
balance analysis any reaction utilizing a cofactor can proceed given that the cofactor can be 587 
recycled by a different reaction, which is a less restrictive constraint on the metabolic network 588 
flux. Furthermore, our implementation allows for inequality or equality mass balance constraints. 589 
Traditional flux balance imposes an equality mass balance which is often referred to as a steady 590 
state constraint. This constraint restricts the rate of change of all metabolite concentrations to be 591 
equal to 0. We provide the option of implementing inequality mass balance, which constrains the 592 
rate of change of metabolite concentrations to be greater than or equal to 0. In practice, 593 
inequality mass balance is implemented by adding unbounded exporting exchange reactions and 594 
calculating steady state solutions. We have implemented inequality mass balance for all of our 595 
calculations due to the fact that we are analyzing local properties of the metabolic network (the 596 
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production of a single metabolite) and do not want the network to be constrained by the global 597 
requirement to achieve steady state. During the production of a particular metabolite, the 598 
metabolic network is thus free to produce byproducts that are used elsewhere or secreted. To 599 
determine production feasibility, the export of a particular target metabolite is set to the objective 600 
function and maximized. If the maximal flux is greater than a hard-coded threshold (>0.001), 601 
then the target metabolite is considered to be feasibly produced. This function uses the COBRA 602 
commands changeObjective and optimizeCbModel to set and maximize the appropriate objective 603 
function. Mathematically, flux balance analysis is implemented as a linear programming problem 604 
with the following definition: 605 
𝒎𝒂𝒙𝒊𝒎𝒊𝒛𝒆: 𝐶𝑇𝑣 606 
𝒔𝒖𝒃𝒋𝒆𝒄𝒕 𝒕𝒐: 𝑆𝑣 = 0 (𝑒𝑞𝑢𝑎𝑙𝑖𝑡𝑦 𝑚𝑎𝑠𝑠 𝑏𝑎𝑙𝑎𝑛𝑐𝑒); 𝑜𝑟 𝑆𝑣 ≥ 0 (𝑖𝑛𝑒𝑞𝑢𝑎𝑙𝑖𝑡𝑦 𝑚𝑎𝑠𝑠 𝑏𝑎𝑙𝑎𝑛𝑐𝑒) 607 
𝒂𝒏𝒅 𝒔𝒖𝒃𝒋𝒆𝒄𝒕 𝒕𝒐: 𝑙𝑏 ≤ 𝑣 ≤ 𝑢𝑏 608 
Where: 𝐶𝑇 is the transpose of a column vector indicating which reactions are to be maximized. 609 
In this case, this specifies the exporting exchange reactions corresponding to the target 610 
metabolites. 𝑣 is a column vector of metabolic reaction fluxes. 𝑆 is the stoichiometric matrix 611 
describing the reactions present in the metabolic network. This is a metabolites by reactions size 612 
matrix. Each element in the matrix is the stoichiometry of a particular metabolite associated with 613 
a particular reaction. Negative values indicate that a metabolite is a reactant of that reaction 614 
being consumed, while positive values indicate that a metabolite is a product of that reaction 615 
being produced. 𝑙𝑏 and 𝑢𝑏 are the lower and upper bounds of all reactions, which define reaction 616 
reversibility or are set to -1000 and 1000 respectively when unbounded. Additional information 617 
on flux balance analysis can be found in this publication describing its implementation in 618 
detail46. 619 
rand_add – This function is designed to give a random sample of input metabolites to be added 620 
based on the Bernoulli parameter for each input metabolite. This function uses the MATLAB 621 
rand function to choose a random number between 0 and 1 for each input metabolite. If this 622 
number is less than the Bernoulli parameter for that input metabolite, then the metabolite is 623 
added. 624 
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prob – This function utilizes rand_add and feas to determine the probability of producing the 625 
target metabolite given the input metabolite Bernoulli parameters, the metabolic network 626 
structure, and the specified constraints. A chosen number of random samples of input 627 
metabolites are generated by repeatedly running the rand_add function. The probability of 628 
producing the target metabolite is determined as the number of feasible trials divided by the total 629 
number of samples. The default number of samples used for the bulk of the analysis in this work 630 
was 50. 631 
calc_PM_fit_nonlin – This function calculates the PM for a specified metabolic network model 632 
and metabolite using an efficient nonlinear fitting technique. The nonlinear fitting algorithm 633 
estimates the PM by randomly sampling points on the PC that fall near PM. The algorithm starts 634 
by sampling a point in the middle of the PC and then using the MATLAB function lsqnonlin to 635 
fit a sigmoidal curve to the sampled points of the PC. The fit sigmoidal curve is used to estimate 636 
the PM. Next, a new sample point is obtained which is offset from the estimated PM value with 637 
some noise introduced with the specified noise parameter. In this way the algorithm converges 638 
on the PM value and samples points around PM, thus increasing the accuracy of its estimate with 639 
each iteration. The estimate converges when a specified n estimates of the PM value are all 640 
within a specified threshold. The code allows for a figure to be displayed which shows the 641 
sampled data points and fit sigmoidal functions, which is useful for debugging the algorithm and 642 
finding suitable parameters. The default parameters, associated with this function, used for the 643 
bulk of our analysis were: noise = 0.3, n = 7, thresh = 0.01. The parameters chosen were selected 644 
by hand to provide good performance. 645 
prep_mod – This function is used to prepare the metabolic network model for analysis with our 646 
method. The input for this function is a COBRA model, which is saved as a MATLAB structure 647 
variable. This code has been developed and optimized to work with KBase generated metabolic 648 
networks and is not guaranteed to work with networks from other sources that have different 649 
naming conventions. The first modification to the networks is to find and turn off all exchange 650 
and maintenance reactions to standardize the network models. Second, the extracellular and 651 
intracellular metabolites are identified based on naming conventions and output from the 652 
function. Third, exchange reactions are added for each metabolite (producing 1 unit of that 653 
metabolite), and a vector indicating the mapping from metabolites to these exchange reactions is 654 
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output from the function. This vector is used by our method to control the presence and absence 655 
of input metabolites in the network model as well as to adjust the inequality mass balance 656 
constraints. The final output is a new network model which has been standardized for our 657 
method and in which the presence and absence of metabolites can be easily manipulated. 658 
find_PM_mods_mets – This function is designed to facilitate the parallelization of the PM 659 
calculation. The function takes as inputs a directory of metabolic network models, a directory to 660 
store results, a list of target metabolite names, the index of the current network model and 661 
metabolite being analyzed and all of the specifications necessary for running 662 
calc_PM_fit_nonlin. The metabolite and model being analyzed can be changed dynamically to 663 
allow for parallelization. In addition to these inputs, this function has several inputs that allow 664 
for standard modifications to the PM calculation procedure. It allows for certain metabolites to 665 
be fixed on or off. It allows for several choices of metabolites to be added during the PM 666 
calculation process, including adding all intracellular or extracellular metabolites and including 667 
the target metabolite or not. It also allows for specification of the inequality mass balance 668 
constraint as either all metabolites set to inequality mass balance or all metabolites set to equality 669 
mass balance. Furthermore, it has a parameter for the number of runs to calculate the PM to 670 
obtain statistics regarding the variability of calc_PM_fit_nonlin. For the analysis done in this 671 
work: calculation of PM for single metabolites was done by adding all intracellular metabolites 672 
(excluding targets). The mass balance constraint was set to use inequality constraints for all 673 
metabolites. The number of runs was set to 10. 674 
Parallelization 675 
We used the Boston University shared computing cluster to run our analysis for a large number 676 
of metabolic networks and metabolites. The calculation of the PM for each individual network 677 
model and metabolite can be run in parallel, vastly increasing the number of possible 678 
computations. The average runtime for computing the PM for an individual network and 679 
metabolite for 10 repeated runs was ~9 minutes and the maximum run time was ~45 minutes, 680 
given the default parameters used in this study: a = 0, s = 1, samp = 50, noise = 0.3, n = 7, thresh 681 
= 0.01, runs = 10. 682 
Analysis of the E. coli core metabolic network 683 
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Our analysis method was initially demonstrated on the E. coli core metabolic network. We used 684 
the network provided by the BiGG database102. We calculated the PM value for each intracellular 685 
metabolite. The input metabolites for our PM calculations were assigned as all intracellular 686 
metabolites. This was the most naïve assumption we could use for assigning input metabolites. 687 
Additionally, using intracellular metabolites as input metabolites avoids errors that could arise 688 
from poorly annotated transporters in draft metabolic network reconstructions. Calculations were 689 
performed using the Boston University shared computing cluster to parallelize runs across 690 
networks and metabolites and improve computation time. The results of our simulation were 691 
visualized using the Cytoscape network visualization software96. The entire E. coli core 692 
metabolic network is shown, excluding the biomass reaction for clarity. 693 
Reconstruction of human oral microbiome metabolic networks 694 
A set of 456 draft metabolic networks were reconstructed for oral microbiome strains. Strains 695 
were chosen to match the sequences chosen for dynamic annotation on HOMD which cover at 696 
least one strain for each sequenced species and repeated strains for sequences of particular 697 
interest for the human oral microbiome. Several strains were additionally selected due to our 698 
interest in fastidious and uncultivated organisms. These included 8 uncultivated or recently co-699 
cultured strains. When considering the taxa TM7 and Tannerella sp. oral taxon 286, we chose to 700 
include the most recent genome sequences from oral microbiome co-culture experiments, 701 
although there are several additional single-cell and metagenome assembled sequences also 702 
available for Tannerella sp. oral taxon 286 and TM7 in particular15, 29,103–105. The host strains 703 
Actinomyces odontolyticus XH001, Pseudopropionibacterium propionicum F0700, and 704 
Pseudopropionibacterium propionicum F0230a were included due to their support of TM7 705 
organisms in co-culture. All genomes were either found in the KBase central data repository or 706 
manually annotated with RAST and uploaded to KBase70,71,106,107. Strains that were dynamically 707 
annotated on HOMD but could not be found on KBase, were not of interest due to 708 
uncultivability, and already had a representative strain from their matching species were not 709 
included in our set of strains. Several naming discrepancies existed between KBase and HOMD, 710 
which are highlighted in the KBase download notes column of Supplementary Table 1. All 711 
metabolic networks were reconstructed using a KBase narrative containing all of the genomes 712 
and metabolic networks from this work, which is available to be copied, viewed, edited, or 713 
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shared at https://narrative.kbase.us/narrative/ws.27853.obj.935. Metabolic networks were 714 
reconstructed for each strain with automatic assignment of Gram-stain, and without gap-filling. 715 
Metabolic network reconstructions were then downloaded from KBase as SBML files and 716 
converted to COBRA .mat files using the COBRA command readCbModel. Metadata related to 717 
all organisms and metabolic networks are available in Supplementary Table 1. 718 
Large-scale analysis of biosynthetic capabilities across the human oral microbiome 719 
We investigated the large-scale biosynthetic properties of the human oral microbiome by 720 
analyzing reconstructed metabolic networks for 456 different oral microbiome strains. For each 721 
metabolic network we calculated the PM value for 88 individual biomass components (40,128 722 
total PM calculations). The biomass components were chosen to be the union of the set of default 723 
KBase Gram-positive and Gram-negative biomass compositions (see Supplementary Table 2 for 724 
details). The metabolites sulfate and phosphate were not included, while the metabolite H2O was 725 
included as a positive control. The calculations were parallelized across metabolic networks and 726 
metabolites using the Boston University shared computing cluster to improve computation time. 727 
The PM values were stored as a matrix of organisms by metabolites PM values. This matrix was 728 
analyzed using hierarchical bi-clustering based on average differences between groups. The 729 
matrix was clustered and visualized using the R package pheatmap. 730 
For the comparison of average PM values and genome size, genome size was taken from KBase 731 
and added to Supplementary Table 1. We used regression modeling to identify the broad 732 
relationship between genome size, taxonomy, and the average PM value. We fit PM values to 733 
linear and quadratic models of log genome size: 734 
Linear: 𝑎𝑣𝑒𝑟𝑎𝑔𝑒(𝑃𝑀) = 𝑐1 + 𝑐2 ∗ log(𝑔𝑒𝑛𝑜𝑚𝑒 𝑠𝑖𝑧𝑒) 735 
Quadratic: 𝑎𝑣𝑒𝑟𝑎𝑔𝑒(𝑃𝑀) = 𝑐1 + 𝑐2 ∗ log(𝑔𝑒𝑛𝑜𝑚𝑒 𝑠𝑖𝑧𝑒) + 𝑐3 ∗ log (𝑔𝑒𝑛𝑜𝑚𝑒 𝑠𝑖𝑧𝑒)2 736 
Nominal taxonomic parameters were added to these models to determine if they could improve 737 
the models prediction of PM values. Gram-stain was assigned based on KBase default 738 
assignments. Phylum, and Class were assigned based on human oral microbiome database 739 
taxonomy annotations. Regression models were developed using the MATLAB command fitlm. 740 
The AIC and BIC were calculated to assess model improvement upon subsequent addition of 741 
taxonomic parameters by determining if the likelihood of the model was improved while 742 
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including a penalty term for each additional independent variable. Independent variables were 743 
added for each additional nominal parameter added (for example: adding the predictor of phyla 744 
meant adding 12 independent variables, one for each different phylum). The AIC and BIC were 745 
calculated using the MATLAB command aicbic. 746 
Capturing specific biosynthetic patterns across human oral microbiome organisms 747 
We investigated specific trends in metabolite PM values related to taxonomy by analyzing the 748 
clustered matrix of PM values. Additionally, a similar regression model was used to provide 749 
quantitative insight. The base model was a quadratic model using the log of genome size as the 750 
predictor of the specific PM value for a certain metabolite across all organisms: 751 
𝑃𝑀(𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒) = 𝑐1 + 𝑐2 ∗ log(𝑔𝑒𝑛𝑜𝑚𝑒 𝑠𝑖𝑧𝑒) + 𝑐3 ∗ log (𝑔𝑒𝑛𝑜𝑚𝑒 𝑠𝑖𝑧𝑒)2 752 
Nominal taxonomic parameters were added one at a time. Taxonomic parameters of Gram-stain 753 
(+ or -), phylum (belonging to 1 of 12 phyla or not) and class (belonging to 1 of 22 classes or 754 
not) were used. We calculated the log likelihood ratio by taking difference between the log 755 
likelihood of the base quadratic model of genome size and the model including a specific 756 
taxonomic parameter. We identified highly significant relationships using an alpha value of 10-6 757 
and Bonferroni correction for multiple hypothesis testing. 758 
Uncovering biosynthetic deficiencies in fastidious human oral microbiome organisms 759 
A subset of fastidious organisms identified from the larger clustered matrix of all oral 760 
microbiome organisms PM values were re-clustered and analyzed further. The clustering method 761 
used was the same as for the larger Figure 3. Additionally, three previously uncultivated TM7 762 
organisms (TM7x, AC001, and PM004) and several host strains for the uncultivated TM7 763 
(Actinomyces odontolyticus XH001, Pseudopropionibacterium propionicum F0700, and 764 
Pseudopropionibacterium propionicum F0230a) were re-clustered and analyzed. Metabolites 765 
were ranked and analyzed based on the difference between the average PM value of separate 766 
groups. Three different ranking were used throughout this analysis 1) average fastidious cluster 767 
organisms PM subtracted from average oral microbiome organisms PM 2) average Mycoplasma 768 
PM subtracted from average TM7 PM 3) average TM7 host PM subtracted from TM7 PM. 769 
Correlations between amino acid biosynthetic cost72 and difference in PM were calculated using 770 
Spearman’s rank correlation and the MATLAB command corr. 771 
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